Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Open Access
- 23 October 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 888
Abstract
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead to recurrent attacks of optic neuritis, myelitis and/or brainstem syndromes. In some patients with symptoms of NMOSD, no AQP4-Abs but Abs against myelin-oligodendrocyte-glycoprotein (MOG) are detectable. These clinical syndromes are now frequently referred to as “MOG-encephalomyelitis” (MOG-EM). Here we give an overview on current recommendations concerning diagnosis of NMOSD and MOG-EM. These include antibody and further laboratory testing, MR imaging and optical coherence tomography. We discuss therapeutic options of acute attacks as well as longterm immunosuppressive treatment, including azathioprine, rituximab, and immunoglobulins.Keywords
This publication has 246 references indexed in Scilit:
- Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple SclerosisPLOS ONE, 2013
- Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive studyBMC Neurology, 2013
- The history of neuromyelitis opticaJournal of Neuroinflammation, 2013
- Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin lossActa Neuropathologica, 2012
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsJournal of Neuroinflammation, 2012
- Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in GermanyTherapeutic Advances in Neurological Disorders, 2012
- Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceJournal of Neuroinflammation, 2010
- Elevated Intrathecal Myelin Oligodendrocyte Glycoprotein Antibodies in Multiple SclerosisArchives of Neurology, 2010
- Antibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain, 2008
- Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2007